SCHEMBL6877620

SCHEMBL6877620

COc1cc2cc(C(=O)OC(C)(C)C)[nH]c2cc1F

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 5/20 0.41
▸ MEN1 O00255 4/20 0.41
▸ POLB P06746 3/20 0.41
▸ RXFP1 Q9HBX9 2/20 0.40
▸ SRD5A1 P18405 1/20 0.40
▸ SRD5A2 P31213 1/20 0.40
▸ FLT3 P36888 3/20 0.39
▸ KDM4E B2RXH2 2/20 0.39
▸ NPC1 O15118 2/20 0.39
▸ ALDH1A1 P00352 2/20 0.39
▸ LMNA P02545 2/20 0.39
▸ HPGD P15428 2/20 0.39
▸ RAB9A P51151 2/20 0.39
▸ HTT P42858 1/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ EIF4A3 P38919 1/20 0.38
▸ MTNR1A P48039 1/20 0.38
▸ MTNR1B P49286 1/20 0.38
▸ PDGFRB P09619 1/20 0.38
▸ PDGFRA P16234 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28909245 0.87 EIF4A3 (0.46) KMT2AMEN1FLT3KDM4ENPC1
SCHEMBL1144949 0.81 SRD5A2 (0.56) KMT2AMEN1POLBRXFP1SRD5A1
SCHEMBL30804502 0.81 GRIN2D (0.44) KMT2AMEN1POLBRXFP1SRD5A1
SCHEMBL7086766 0.81 KDM4E (0.60) KMT2AMEN1RXFP1SRD5A1SRD5A2
SCHEMBL8985887 0.80 POLB (0.47) KMT2AMEN1POLBRXFP1SRD5A1
SCHEMBL25724364 0.76 KDM4E (0.60) KMT2AMEN1RXFP1SRD5A1SRD5A2
SCHEMBL1144612 0.76 EIF4A3 (0.60) KMT2AMEN1POLBRXFP1SRD5A1
SCHEMBL6877979 0.75 GABRA1 (0.45) KMT2AMEN1POLBFLT3KDM4E
SCHEMBL10003170 0.74 IDH1 (0.41) KMT2AMEN1POLBRXFP1SRD5A1
SCHEMBL31219118 0.73 XDH (0.51) KMT2AMEN1FLT3KDM4ENPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1474420-A1 QUINAZOLINE COMPOUNDS Astrazeneca AB (SE) 2004-11-10 — — EP disclosed
WO-2003064413-A1 QUINAZOLINE COMPOUNDS ASTRAZENECA AB (SE) 2003-08-07 — — WO disclosed
EP-1313726-A1 QUINOLINE DERIVATIVES HAVING VEGF INHIBITING ACTIVITY AstraZeneca AB (SE) 2003-05-28 — — EP disclosed
EP-1311500-A2 INDOLE, AZAINDOLE AND INDAZOLE DERIVATIVES HAVING VEGF INHIBITING ACTIVITY AstraZeneca AB (SE) 2003-05-21 — — EP disclosed
EP-1309587-A1 CINNOLINE COMPOUNDS AstraZeneca AB (SE) 2003-05-14 — — EP disclosed
WO-2002012228-A1 CINNOLINE COMPOUNDS ASTRAZENECA AB (SE) 2002-02-14 — — WO disclosed
WO-2002012226-A1 QUINOLINE DERIVATIVES HAVING VEGF INHIBITING ACTIVITY ASTRAZENECA AB (SE) 2002-02-14 — — WO disclosed
WO-2002012227-A2 INDOLE, AZAINDOLE AND INDAZOLE DERIVATIVES HAVING VEGF INHIBITING ACTIVITY ASTRAZENECA AB (SE) 2002-02-14 — — WO disclosed
Send feedback